Alene A. Campbell
Directeur Général chez Kindara, Inc.
Profil
Alene A.
Campbell currently works at Kindara, Inc., as Chief Executive Officer & Director.
Ms. Campbell also formerly worked at Prima Temp, Inc., as Chief Executive Officer, Atugen AG, as Chief Executive Officer, MicroPhage, Inc., as Chief Executive Officer, Cell Genesys, Inc., as Principal, Sirna Therapeutics, Inc., as Vice President-Corporate Development, Gilead Colorado, Inc., as Vice President-Corporate Development, BaroFold, Inc., as Chief Business Officer, and Ritter Pharmaceuticals, Inc., as Head-Operations & Corporate Development.
Ms. Campbell received her Masters Business Admin degree from the University of California, Berkeley.
Postes actifs de Alene A. Campbell
| Sociétés | Poste | Début |
|---|---|---|
Kindara, Inc.
 Kindara, Inc. Packaged SoftwareTechnology Services Kindara, Inc. develops an application for men and women for serious fertility charting. It provides software, education and support to help women and couples learn about fertility, understand their bodies, and maximize their chances of getting pregnant. The company was founded by William Sacks and Katherine Bicknell in 2011 and is headquartered in Boulder, CO. | Directeur Général | - |
Anciens postes connus de Alene A. Campbell
| Sociétés | Poste | Fin |
|---|---|---|
Prima Temp, Inc.
 Prima Temp, Inc. Electronic Equipment/InstrumentsElectronic Technology Prima Temp, Inc. develops wireless, continuous core temperature sensing. Its product, Priya, is an internal sensor that provides fertility detection, early disease detection, obesity and weight loss, heat exhaustion, sleep disorders, and cancer chemotherapy treatment. The product then sends the data to the connected smartphone. The company was founded by Wade Webster and Rich Pollack and is headquartered in Boulder, CO. | Directeur Général | - |
MicroPhage, Inc.
 MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | President | - |
| QUALIGEN THERAPEUTICS, INC. | Directeur des opérations | - |
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Corporate Officer/Principal | - |
Atugen AG
 Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Corporate Officer/Principal | - |
Formation de Alene A. Campbell
| University of California, Berkeley | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
BaroFold, Inc.
 BaroFold, Inc. Pharmaceuticals: MajorHealth Technology BaroFold, Inc. develops and commercializes protein therapeutics. Its services include protein refolding, protein analytical and aggregate characterization, formulation stability and immunogenicity studies, and microbial expression. The company was founded by Matthew Seefeldt, Matthew Brewer, John F. Carpenter, Ted Randolph, Timothy C. Rodell, and Lyndal K. Hesterberg in 2009 and is headquartered in Aurora, CO. | Health Technology |
Gilead Colorado, Inc.
 Gilead Colorado, Inc. Pharmaceuticals: MajorHealth Technology Gilead Colorado, Inc. is a biopharmaceutical company that develops and markets drugs used for cardiovascular disorders. Their products include discovery of novel therapies and product identification and acquisition. The company was founded in 1996 and is headquartered in Westminster, CO. | Health Technology |
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
Atugen AG
Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Health Technology |
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
MicroPhage, Inc.
MicroPhage, Inc. Medical/Nursing ServicesHealth Services MicroPhage, Inc. provides clinical product development services. The firm develops and markets bacterial identification and antibiotic susceptibility through its bacteriophage-based amplification platform for immunoassay diagnostics. The company was founded by Jack Wheeler and Kent Voorhees in June 2002 and is headquartered in Longmont, CO. | Health Services |
Ritter Pharmaceuticals, Inc.
 Ritter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA. | Health Technology |
Kindara, Inc.
Kindara, Inc. Packaged SoftwareTechnology Services Kindara, Inc. develops an application for men and women for serious fertility charting. It provides software, education and support to help women and couples learn about fertility, understand their bodies, and maximize their chances of getting pregnant. The company was founded by William Sacks and Katherine Bicknell in 2011 and is headquartered in Boulder, CO. | Technology Services |
Prima Temp, Inc.
Prima Temp, Inc. Electronic Equipment/InstrumentsElectronic Technology Prima Temp, Inc. develops wireless, continuous core temperature sensing. Its product, Priya, is an internal sensor that provides fertility detection, early disease detection, obesity and weight loss, heat exhaustion, sleep disorders, and cancer chemotherapy treatment. The product then sends the data to the connected smartphone. The company was founded by Wade Webster and Rich Pollack and is headquartered in Boulder, CO. | Electronic Technology |
